IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndromes; Acute Myeloid Leukemia Intervention: Drug: AG-120 Sponsor: Groupe Francophone des Myelodysplasies Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Leukemia | Myelodysplastic Syndrome